Machine learning based analysis of leucocyte cell population data by Sysmex XN series hematology analyzer for the diagnosis of bacteremia.

Journal: Scientific reports
Published Date:

Abstract

In clinical practice, early recognition of bacteremia leads to prognostic improvement. Recently, cell population data (CPD) from the Sysmex XN-series hematology analyzer has attracted attention as a new method for the early diagnosis of bacteremia, but its usefulness in clinical practice remains unclear. We focused on the fluorescent light distribution of the neutrophil area (NE-WY) and used machine learning to determine whether predictions could be improved. Among adult patients with clinically suspected bacteremia at our hospital, 533 who did not meet the exclusion criteria were enrolled. Propensity score matching was performed for bacteremia (n = 106) and non-bacteremia (n = 427) cases. NE-WY showed the largest difference between the two groups (AUC, 0.768; sensitivity, 73.6%; specificity, 67.9%; cutoff value, 686.5(no unit)). In machine learning, the first branch of the decision tree was NE-WY, and the cutoff value was set at 689.5(no unit). Support vector machines were used to examine multiple variables, but there were no significant differences relative to NE-WY alone. This is the first report to demonstrate that NE-WY is useful for detecting bacteremia by analyzing CPD using machine learning. The combination of CPD and machine learning is expected to produce new results.

Authors

  • Sadashi Horie
    Department of Pediatrics, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. sadashih@med.u-toyama.ac.jp.
  • Mizuki Yamashita
    Department of Clinical Laboratory and Transfusion Medicine & Cell Therapy Center, Toyama University Hospital, Toyama, Japan.
  • Kenta Matsumura
    Graduate School of Health Sciences, Aomori University of Health and Welfare, Aomori, Japan.
  • Yoji Uejima
    Department of Infectious Diseases, Immunology and Allergy, Saitama Prefectural Children's Medical Center, Saitama, Japan.
  • Makito Kaneda
    Department of Clinical Infectious Diseases, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Kentaro Nagaoka
    Department of Clinical Infectious Diseases, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Kentaro Tamura
    Department of Pediatrics, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Kenu Harada
    Department of Clinical Laboratory and Transfusion Medicine & Cell Therapy Center, Toyama University Hospital, Toyama, Japan.
  • Yoshihiro Yamamoto
    Department of Clinical Infectious Diseases, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Isao Kitajima
    Clinical Laboratory Center, Toyama University Hospital, Toyama City, Japan.
  • Chihaya Imai
    Department of Pediatrics, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Hideki Niimi
    Clinical Laboratory Center, Toyama University Hospital, Toyama City, Japan.